Rhinitis treating medicine

Abstract

The invention discloses a rhinitis treating medicine which is prepared from the following raw materials by weight: 50 grams of radix astragali, 50 grams of radix bupleuri, 50 grams of rhizoma cimicifugae, 50 grams of Chinese angelica root, 50 grams of radix et rhizoma ginseng, 50 grams of rhizoma anemarrhenae, 50 grams of cortex phellodendri chinensis, 50 grams of fructus corni, 50 grams of radixrehmanniae preparata, 50 grams of cortex moutan, 50 grams of rhizoma dioscoreae, 50 grams of poria cocos, 50 grams of rhizoma alismatis, 50 grams of prepared aconite root, 50 grams of cortex cinnamomi, 50 grams of flos magnoliae, 50 grams of fructus xanthii, 50 grams of herba centipedae, 50 grams of rhizoma chuanxiong, 50 grams of bighead atractylodes rhizome, 50 grams of liquorice root, 50 gramsof herba patriniae, 50 grams of earthworm, 50 grams of semen coicis, 1000 grams of brown sugar, 1500 milliliters of water and 1000 grams of honey. Compared with the prior art, the rhinitis treating medicine disclosed by the invention has the advantages of effects of treating varieties of acute or chronic rhinitis, allergic rhinitis, nasosinusitis and nasal turbinate hypertrophy and improving repeated snot, nasal mucus, nasal obstruction, smell loss and the like.

Description

technical field [0001] The invention relates to the technical field of medical products, in particular to a medicine for treating rhinitis. Background technique [0002] Rhinitis (including sinusitis and allergic rhinitis) is an infectious disease of the nasal mucosa caused by weakness of the lung, spleen, and kidney, and invasion of wind-cold or wind-heat pathogens. Clinically, it is a common and frequently-occurring disease with episodic nasal congestion, nasal itching, sneezing, runny nose, headache, dizziness, memory loss and turbinate swelling as the main symptoms. At present, there are many drugs and methods for treating rhinitis on the market, but there are certain limitations to varying degrees. In particular, the functional endoscopic sinus surgery carried out in recent years is generally advisable for adults, but it is generally not advisable for children, because children aged 6-12 have immature sinuses, low resistance and poor immunity. Coupled with the poor co...

AI Technical Summary

Problems solved by technology

At present, there are many drugs and methods for treating rhinitis on the market, but there are certain limitations to varying degrees.

In particular, the functional endoscopic sinus surgery carried out in recent years is generally advisable for adults, but it is generally not advisable for children, because children aged 6-12 have immature sinuses, low resistance and poor immunity. Coupled with the poor cooperation of children, some children relapse after a period of time after operation, and even complications occur. Generally, surgery is not advocated. Therefore, it is urgent to invent a method that is suitable for both adults and children, simple and cheap, efficient and safe, and easy to be used. Treatment options received by the patient